(Q72243690)
Statements
[A trial of the use of the prolonged-action preparation Koldakt from the Natko firm for treating upper respiratory tract diseases in polyclinics] (English)
Rumiantsev AG
Aldonina VV
Il'ina TP
Snitarenko VIu
Biriuchinskaia IG